Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
Deloitte
US Department of Justice
Teva
Moodys
Harvard Business School
McKinsey
Mallinckrodt

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021300

« Back to Dashboard

NDA 021300 describes CLARINEX, which is a drug marketed by Merck Sharp Dohme and is included in five NDAs. It is available from one supplier. There are eight patents protecting this drug and four Paragraph IV challenges. Additional details are available on the CLARINEX profile page.

The generic ingredient in CLARINEX is desloratadine; pseudoephedrine sulfate. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.
Summary for 021300
Tradename:CLARINEX
Applicant:Merck Sharp Dohme
Ingredient:desloratadine
Patents:1
Pharmacology for NDA: 021300
Suppliers and Packaging for NDA: 021300
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARINEX desloratadine SOLUTION;ORAL 021300 NDA Merck Sharp & Dohme Corp. 0085-1334 0085-1334-01 1 BOTTLE in 1 CARTON (0085-1334-01) > 473 mL in 1 BOTTLE
CLARINEX desloratadine SOLUTION;ORAL 021300 NDA Merck Sharp & Dohme Corp. 0085-1334 0085-1334-02 1 BOTTLE in 1 CARTON (0085-1334-02) > 118 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength0.5MG/ML
Approval Date:Sep 1, 2004TE:AARLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Dec 1, 2018Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021300

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme CLARINEX desloratadine SOLUTION;ORAL 021300-001 Sep 1, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme CLARINEX desloratadine SOLUTION;ORAL 021300-001 Sep 1, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme CLARINEX desloratadine SOLUTION;ORAL 021300-001 Sep 1, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme CLARINEX desloratadine SOLUTION;ORAL 021300-001 Sep 1, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Farmers Insurance
Merck
Argus Health
Harvard Business School
Teva
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.